
The indemnity will not just impact domestic rules but also set a precedent for the future with other drug-makers also expected to seek similar facility for life-saving medicines. In addition, this could be demanded for other purchases too. The demand for an overseas jurisdiction for resolving disputes in particular has seen the Centre consider the consequences.